T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Match Group
MTCH
|
+$3.31B |
| 2 |
Nike
NKE
|
+$2.27B |
| 3 |
FedEx
FDX
|
+$2.24B |
| 4 |
Bank of America
BAC
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.64B |
Top Sells
| 1 |
IAC Inc
IAC
|
+$3.91B |
| 2 |
Fortive
FTV
|
+$2.68B |
| 3 |
Alibaba
BABA
|
+$1.51B |
| 4 |
Linde
LIN
|
+$1.51B |
| 5 |
Willis Towers Watson
WTW
|
+$1.16B |
Sector Composition
| 1 | Technology | 25.65% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.89% |
| 4 | Financials | 11.37% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Merit Medical Systems
MMSI
$4.91B
| $31M | ﹤0.01% |
712,727
-298
| -0% | -$13K |
|
1027
Schrodinger
SDGR
$1.36B
| $31M | ﹤0.01% |
652,317
-99,640
| -13% | -$4.73M |
|
1028
Amcor
AMCR
$19.1B
| $31M | ﹤0.01% |
2,802,873
-144,910
| -5% | -$1.6M |
|
1029
Onto Innovation
ONTO
$5.7B
| $30.9M | ﹤0.01% |
1,035,924
-58,590
| -5% | -$1.74M |
|
1030
Independent Bank
INDB
$3.54B
| $30.6M | ﹤0.01% |
584,534
-76,732
| -12% | -$4.02M |
|
1031
Aaon
AAON
$6.81B
| $30.4M | ﹤0.01% |
756,848
+3,221
| +0.4% | +$129K |
|
1032
EPAM Systems
EPAM
$8.61B
| $30.4M | ﹤0.01% |
93,887
-21,289
| -18% | -$6.88M |
|
1033
Madison Square Garden
MSGS
$5.07B
| $30.2M | ﹤0.01% |
200,645
+193,153
| +2,578% | +$29.1M |
|
1034
Atkore
ATKR
$2.08B
| $30.2M | ﹤0.01% |
1,327,924
+33,316
| +3% | +$757K |
|
1035
Arcturus Therapeutics
ARCT
$492M
| $30.2M | ﹤0.01% |
703,386
+185,549
| +36% | +$7.96M |
|
1036
TherapeuticsMD
TXMD
$12.5M
| $30.1M | ﹤0.01% |
381,156
-2,282
| -0.6% | -$180K |
|
1037
Kellanova
K
$27.5B
| $29.9M | ﹤0.01% |
493,783
-14,983
| -3% | -$909K |
|
1038
Matador Resources
MTDR
$5.79B
| $29.7M | ﹤0.01% |
3,595,996
+524,364
| +17% | +$4.33M |
|
1039
FormFactor
FORM
$2.37B
| $29.5M | ﹤0.01% |
1,181,887
+1,149,982
| +3,604% | +$28.7M |
|
1040
Silgan Holdings
SLGN
$4.63B
| $29.4M | ﹤0.01% |
800,421
-128,369
| -14% | -$4.72M |
|
1041
Perdoceo Education
PRDO
$2.27B
| $29.4M | ﹤0.01% |
2,400,919
| – | – |
|
1042
Arcutis Biotherapeutics
ARQT
$2.03B
| $29M | ﹤0.01% |
991,021
-75,519
| -7% | -$2.21M |
|
1043
Intellia Therapeutics
NTLA
$1.24B
| $29M | ﹤0.01% |
1,458,005
+104,691
| +8% | +$2.08M |
|
1044
Crown Holdings
CCK
$11.1B
| $28.9M | ﹤0.01% |
375,834
+315,199
| +520% | +$24.2M |
|
1045
Annexon
ANNX
$274M
| $28.9M | ﹤0.01% |
+954,410
| New | +$28.9M |
|
1046
NewMarket
NEU
$7.81B
| $28.8M | ﹤0.01% |
84,220
-12,691
| -13% | -$4.34M |
|
1047
Fabrinet
FN
$12.8B
| $28.6M | ﹤0.01% |
454,478
+400,910
| +748% | +$25.3M |
|
1048
Douglas Dynamics
PLOW
$749M
| $28.6M | ﹤0.01% |
836,249
+6,178
| +0.7% | +$211K |
|
1049
Hope Bancorp
HOPE
$1.39B
| $28.6M | ﹤0.01% |
3,768,081
-335,960
| -8% | -$2.55M |
|
1050
Ventas
VTR
$31.7B
| $28.4M | ﹤0.01% |
677,576
-23,832
| -3% | -$1,000K |
|